|
業務類別
|
Biotechnology |
|
業務概覽
|
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others. |
| 公司地址
| 188 East Blaine Street, Suite 400, Seattle, WA, USA, 98102 |
| 電話號碼
| +1 206 701-7914 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.sana.com |
| 員工數量
| 194 |
| Mr. Brian D. Piper, M.B.A. |
Executive Vice President, Treasurer and Chief Financial Officer |
-- |
17/02/2026 |
| Mr. Aaron M. Grossman |
Executive Vice President and Chief Legal Officer |
-- |
05/09/2025 |
| Ms. Susan Wyrick |
Principal Accounting Officer and Senior Vice President, Finance and Accounting |
-- |
03/03/2026 |
| Dr. Steven D. Harr, M.D. |
President, Chief Executive Officer and Director |
美元 680.99K |
17/02/2026 |
|
|
| Ms. Michelle Seitz, C.F.A. |
Independent Director |
03/03/2026 |
| Dr. Alise S. Reicin, M.D. |
Independent Director |
03/03/2026 |
| Dr. Joshua H. Bilenker, M.D. |
Independent Director |
03/03/2026 |
| Mr. Hans Edgar Bishop |
Chairman of the Board |
03/03/2026 |
| Dr. Richard C. Mulligan, PhD |
Director |
03/03/2026 |
| Mr. Robert Taylor Nelsen |
Independent Director |
03/03/2026 |
| Dr. Patrick Y. Yang, PhD |
Independent Director |
03/03/2026 |
| Mr. Robert L. Rosiello |
Director |
03/03/2026 |
| Dr. Steven D. Harr, M.D. |
President, Chief Executive Officer and Director |
17/02/2026 |
|
|
|
|
